Picture of Genxone SA logo

GX1 Genxone SA Income Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Annual income statement for Genxone SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
PAS
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue23.210.62.391.790.917
Cost of Revenue
Gross Profit15.55.960.5970.640.621
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses12.610.46.616.051.15
Operating Profit10.60.203-4.22-4.26-0.23
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes10.50.63-3.72-3.93-0.207
Provision for Income Taxes
Net Income After Taxes8.770.48-3.72-3.93-0.196
Net Income Before Extraordinary Items
Net Income8.770.48-3.72-3.93-0.196
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income8.770.48-3.72-3.93-0.196
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.660.154-1.13-1.19-0.071
Dividends per Share